This inventor holds 2 USPTO granted patents. Top assignee: Glaxo Wellcome Inc.. Active years: 1999-2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999-2000
Title: The Innovative Contributions of David Brian Hutchinson
Introduction
David Brian Hutchinson, an accomplished inventor based in Beckenham, GB, has made significant strides in the pharmaceutical field with his innovative work. With two patents under his name, Hutchinson's contributions to the treatment of parasitic infections highlight his commitment to advancing medical science.
Latest Patents
Hutchinson's latest patents revolve around the combination of atovaquone and proguanil for the treatment of various protozoal infections. His invention focuses on utilizing these drugs in synergy for the treatment and prophylaxis of parasitic infections, including malaria and toxoplasmosis. The innovative formulation he developed allows for the combination to be administered conveniently in a single pharmaceutical preparation. This synergistic approach enhances the effectiveness of the treatment, presenting a significant advancement in medicinal therapy for infections caused by organisms such as P. carinii.
Career Highlights
David Brian Hutchinson currently works with Glaxo Wellcome Inc., where his research and inventions continue to impact the pharmaceutical industry deeply. His work not only strives to improve treatment outcomes but also emphasizes the importance of innovative drug combinations in tackling complex health challenges.
Collaborations
Throughout his career, Hutchinson has collaborated with accomplished colleagues, including Winston E. Gutteridge and Victoria S. Latter. These partnerships have fostered an environment of innovation and have been instrumental in propelling forward the research and development of new therapeutic strategies.
Conclusion
David Brian Hutchinson exemplifies the essence of innovation within the pharmaceutical industry. His pioneering patents focusing on the combination of atovaquone and proguanil serve as a testament to his dedication to enhancing medical treatments for parasitic infections. As the landscape of medicine continues to evolve, Hutchinson's contributions will undoubtedly leave a lasting impact on patient care and treatment efficacy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile